The Enterprise Value as of June 2026 (TTM) for Hoth Therapeutics, Inc. (HOTH) is 20.84M

According to Hoth Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 20.84M. This represents a change of 112.30% compared to the average of 9.82M of the last 4 quarters.

Hoth Therapeutics, Inc. (HOTH) Historical Enterprise Value (quarterly & annually)

How has HOTH Enterprise Value performed in the past?

The mean historical Enterprise Value of Hoth Therapeutics, Inc. over the last ten years is 28.06M. The current 20.84M Enterprise Value has changed 7.33% with respect to the historical average. Over the past ten years (40 quarters), HOTH's Enterprise Value was at its highest in in the March 2018 quarter at 81.62M. The Enterprise Value was at its lowest in in the March 2023 quarter at -7929764.56.

Hoth Therapeutics, Inc. (HOTH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Hoth Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Hoth Therapeutics, Inc. (HOTH) Average Enterprise Value

How has HOTH Enterprise Value performed in the past?

The current Enterprise Value of Hoth Therapeutics, Inc. (HOTH) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Hoth Therapeutics, Inc. (HOTH) Enterprise Value vs. Peers

How is HOTH’s Enterprise Value compared to its peers?

Hoth Therapeutics, Inc.’s Enterprise Value is greater than Curis, Inc. (-8118049.00), greater than BriaCell Therapeutics Corp. (-1763599.79), less than Palisade Bio, Inc. (164.19M), greater than Processa Pharmaceuticals, Inc. (3.23M), greater than Aspire Biopharma Holdings, Inc. (-4785565.00), greater than Lexaria Bioscience Corp. (7.53M), greater than FibroBiologics, Inc. Common Stock (2.70M), greater than Pulmatrix, Inc. (1.79M), greater than Daré Bioscience, Inc. (7.90M), greater than Entero Therapeutics, Inc. (19.92M),

Build a custom stock screener for Hoth Therapeutics, Inc. (HOTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hoth Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Hoth Therapeutics, Inc. (HOTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Hoth Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.